DENALI THERAPEUTICS INC

Ticker: DNLI CUSIP: 24823R105 Class: Common Stock

T. Rowe Price Investment Management, Inc.'s Holding History (CIK: 0001897612)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 1,245,994 Value ($000) $21 Avg Close $16.88 Range $13.75 - $20.61
Q3 2025
Shares 5,638,567 Value ($000) $82 Avg Close $14.37 Range $12.58 - $16.20
Q2 2025
Shares 3,246,934 Value ($000) $45 Avg Close $14.07 Range $10.57 - $16.97
Q1 2024
Shares 498,969 Value ($000) $10 Avg Close $18.79 Range $15.49 - $23.52
Q4 2023
Shares 498,969 Value ($000) $11 Avg Close $19.81 Range $15.45 - $23.81
Q3 2023
Shares 647,013 Value ($000) $13 Avg Close $25.37 Range $20.52 - $30.79
Q2 2023
Shares 647,013 Value ($000) $19 Avg Close $28.12 Range $22.72 - $33.31
Q1 2023
Shares 647,013 Value ($000) $15 Avg Close $27.52 Range $21.74 - $32.81
Q4 2022
Shares 633,358 Value ($000) $18 Avg Close $29.75 Range $25.96 - $34.78
Q3 2022
Shares 422,357 Value ($000) $12,963 Avg Close $32.51 Range $25.88 - $39.43